Abstract: According to an embodiment, there is provided a control method for autonomously berthing a ship including obtaining ship state information and berth information, setting a DP point; an approaching operation of controlling the ship to approach the DP point; and a dynamic positioning operation of adjusting a location and posture of the ship based on an error rate between the DP point and a current location of the ship.

Abstract: Disclosed is novel use of granulocyte colony-stimulating factor receptor or colony-stimulating factor 3 receptor (CSF3R) as a biomarker and therapeutic target for pulmonary fibrosis. Herein, a treatment mechanism, treatment method, treatment drug, and therapeutic use of the treatment drug containing CSF3R for pulmonary fibrosis are disclosed.

Abstract: The present disclosure relates to an organic electroluminescent compound, a plurality of host materials, and an organic electroluminescent device comprising the same. By comprising the organic electroluminescent compound according to the present disclosure or by comprising a specific combination of compounds according to the present disclosure as a plurality of host materials, it is possible to produce an organic electroluminescent device having improved luminous efficiency, and/or lifetime properties compared to the conventional organic electroluminescent devices.

Abstract: Provided is a compound of Chemical Formula 1: wherein: each X is independently N or CH, provided that at least one X is N; Ar1 and Ar2 are each independently a substituted or unsubstituted C6-60 aryl or a substituted or unsubstituted C5-60 heteroaryl containing one or more of N, O and S; Ar3 is a substituted or unsubstituted C5-60 heteroaryl containing at least one N; D is a substituent of any one of the following Chemical Formulas 2-1 to 2-3: wherein: Y1 is O, S, NR2, or CR3R4; n is an integer of 0 to 10; each R1 is independently hydrogen, deuterium, or a substituted or unsubstituted: C1-60 alkyl, C3-60 cycloalkyl, C6-60 aryl, or C5-60 heteroaryl containing one or more of N, O and S; and R2 to R4 are each independently a substituted or unsubstituted C1-60 alkyl or a substituted or unsubstituted C6-60 aryl, and an organic light emitting device comprising the same.

Abstract: Provided is a heterocyclic compound of Chemical Formula 1: wherein: X is O or S; Y1, Y2 and Y3 are each independently CH or N, provided that at least one is N; L1 and L2 are each independently a direct bond, a substituted or unsubstituted C6-60 arylene, or a substituted or unsubstituted C5-60 heteroarylene containing at least one of N, O and S; and Ar is a substituted or unsubstituted C6-60 aryl, and Ar2 and Ar3 are each independently a substituted or unsubstituted C6-60 aryl or a C5-60 heteroaryl containing at least one of N, O and S, provided that when all of Ar1, Ar2 and Ar3 are a substituted or unsubstituted C6-60 aryl, any one of Ar1, Ar2 and Ar3 is substituted with 4 or more deuteriums; and an organic light emitting device including the same.

Abstract: A method of calculating a collision risk of a ship according to an embodiment of the present disclosure may include: calculating an available velocity area based on maneuvering performance of a host ship; calculating a velocity obstacle area where there is a possibility of collision between an object and the host ship; and calculating a collision risk based on at least one of the available velocity area, the velocity obstacle area, and a preset weight.

Abstract: A sensor shifting module includes a fixed body, a first movable body movably disposed on the fixed body and coupled to an image sensor having an imaging plane oriented in a first direction, and a first driver configured to rotate the first movable body about an axis orthogonal to the first direction with respect to the fixed body, wherein the first driver includes a tilt guide ball disposed between the fixed body and the first movable body to provide a tilt center for the first movable body with respect to the fixed body.

Abstract: Provided is a method and an apparatus for targeting an object in a game. The method of targeting an object in a game includes: setting a center point of a first targeting area based on a first input from a user; displaying the first targeting area surrounded by a closed curve around the center point on a screen of a user terminal; displaying a list including at least one object located in the first targeting area on the screen; and moving the first targeting area based on a second input by the user received after the first input.

Abstract: A sensor shifting actuator is provided. The sensor shifting actuator include a first movable body in which an image sensor having an imaging surface is disposed, a fixed body in which the first movable body is disposed to be movable in first and second directions parallel to the imaging surface, a driving unit configured to provide a driving force to the first movable body, and a position sensing unit configured to sense a position of the first movable body and including a sensing coil disposed on any one of the first movable body and the fixed body and a sensing yoke unit disposed on the other thereof, wherein the sensing yoke unit includes a plurality of sensing yokes spaced apart from each other in a direction orthogonal to the imaging surface, and each sensing yoke is configured to change in width in a moving direction of the first movable body.

Abstract: A new use of M-CSF or G-CSF for diagnosis or treatment of pulmonary fibrosis is disclosed. A marker for diagnosing the level of development or progression of pulmonary fibrosis contains M-CSF and/or G-CSF; and a composition for preventing or treating pulmonary fibrosis, contains an M-CSF inhibitor and a G-CSF inhibitor as active ingredients. The present inventors have ascertained that M-CSF and/or G-CSF is a marker for development or progression of pulmonary fibrosis, and have confirmed that a composition, which contains M-CSF and G-CSF and which binds to M-CSF and G-CSF so that the inherent mechanism thereof can be prevented, has an effect of significantly inhibiting myofibroblast hyperplasia or pulmonary fibrosis of the pulmonary cells, and thus the marker and the composition of the present disclosure are expected to be effectively usable for diagnosis, prevention or treatment of pulmonary fibrosis.

Abstract: Disclosed is a mechanochromic array patch that implements, as a color change, a strain applied to a skin surface due to musculoskeletal movement. The mechanochromic array patch may include stretchable mechanochromic color-changing parts, a polymer connection part that connects the mechanochromic color-changing parts, and a water-insoluble support part. The polymer connection part may have a higher elastic modulus compared to the mechanochromic color-changing parts.

Abstract: Disclosed is a mechanochromic array patch that implements, as a color change, a strain applied to a skin surface due to musculoskeletal movement. The mechanochromic array patch may include stretchable mechanochromic color-changing parts, a polymer connection part that connects the mechanochromic color-changing parts, and a water-insoluble support part. The polymer connection part may have a higher elastic modulus compared to the mechanochromic color-changing parts.

Abstract: Provided is a strain sensor. The strain sensor according to embodiments of the inventive concept includes a flexible substrate, rigid patterns on the flexible substrate, the rigid patterns including a first pattern and a second pattern spaced apart from the first pattern in a first direction, a first electrode on the first pattern, a second electrode on the second pattern, the second electrode being spaced apart from the first electrode, and a piezoresistive layer connecting the first electrode and the second electrode. Here, each of the rigid patterns may have a stiffness greater than that of the flexible substrate.

Abstract: A novel use of granulocyte colony-stimulating factor, also known as colony-stimulating factor 3 (CSF3) is disclosed. An anticancer adjuvant containing an inhibitor of CSF3 is disclosed. Uses of CSF3 as a biomarker or therapeutic target for pulmonary fibrosis are disclosed. In addition, A pharmaceutical composition for treating pulmonary fibrosis containing an inhibitor of CSF3 and a treatment method of pulmonary fibrosis are disclosed.

Abstract: A new use of M-CSF or G-CSF as a useful marker for diagnosis or treatment of pulmonary fibrosis is disclosed. Also disclose are a composition containing M-CSF inhibitor and/or G-CSF inhibitor, as active ingredients, wherein the composition is suitable for preventing or treating pulmonary fibrosis. A composition containing M-CSF inhibitor and/or G-CSF inhibitor which bind to M-CSF and G-CSF, respectively, has an effect of significantly inhibiting myofibroblast hyperplasia or pulmonary fibrosis of the pulmonary cells.

Abstract: Provided is a flexible touch panel.

Abstract: The present disclosure relates to a method for screening a colorectal cancer inhibitor and, more specifically, to a method for screening a colorectal cancer inhibitor wherein a material increasing a binding level of ICAM-1 to SRC is selected as a therapeutic material. In the present disclosure, ICAM-1 is identified to regulate cancer metastasis and angiogenesis in an SRC-dependent manner, thereby exhibiting that ICAM-1 can be a potential target factor for developing a colorectal cancer therapeutic agent. Accordingly, a colorectal cancer therapeutic agent employing the target factor screened by the method of the present disclosure can increase the therapeutic effect for colorectal cancer patients.

Abstract: A new use of M-CSF or G-CSF as a useful marker for diagnosis or treatment of pulmonary fibrosis is disclosed. Also disclose are a composition containing M-CSF inhibitor and/or G-CSF inhibitor, as active ingredients, wherein the composition is suitable for preventing or treating pulmonary fibrosis. A composition containing M-CSF inhibitor and/or G-CSF inhibitor which bind to M-CSF and G-CSF, respectively, has an effect of significantly inhibiting myofibroblast hyperplasia or pulmonary fibrosis of the pulmonary cells.

Abstract: Provided is a flexible touch panel.

Abstract: Provided is a strain sensor. The strain sensor according to embodiments of the inventive concept includes a flexible substrate, rigid patterns on the flexible substrate, the rigid patterns including a first pattern and a second pattern spaced apart from the first pattern in a first direction, a first electrode on the first pattern, a second electrode on the second pattern, the second electrode being spaced apart from the first electrode, and a piezoresistive layer connecting the first electrode and the second electrode. Here, each of the rigid patterns may have a stiffness greater than that of the flexible substrate.